(Q38068364)

28 August 2017

1 reference

title

Pain and multiple sclerosis: pathophysiology and treatment (English)

1 reference

28 August 2017

0 references

1 reference

Claudio Solaro

1

1 reference

28 August 2017

Erika Trabucco

series ordinal

2

1 reference

28 August 2017

Michele Messmer Uccelli

series ordinal

3

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Current Neurology and Neuroscience Reports

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

320

1 reference

Neuropathic pain: redefinition and a grading system for clinical and research purposes

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Pain associated with multiple sclerosis: systematic review and proposed classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Pain syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Acute and chronic pain syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

The scope and nature of pain in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Lifetime and actual prevalence of pain and headache in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Hyperalgesia in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Acquired channelopathies in nerve injury and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

21 January 2018

Sodium channels and pain

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Carbamazepine in the treatment of neuralgia. Use of side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Open label gabapentin treatment for pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Acute delirium in patients with multiple sclerosis treated with pregabalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Trigeminal neuralgia: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Trigeminal neuralgia and pain related to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Trigeminal involvement in multiple sclerosis: magnetic resonance imaging findings with clinical correlation in a series of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Linear pontine trigeminal root lesions in multiple sclerosis: clinical and magnetic resonance imaging studies in 5 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Neurosurgery in Italy: origins to modernity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Idiopathic and symptomatic trigeminal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Topiramate relieves idiopathic and symptomatic trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Radiofrequency trigeminal rhizotomy in treatment of symptomatic non-neoplastic facial pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Reappraisal of Lhermitte's sign in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Management of pain in multiple sclerosis: a pharmacological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Psychological aspects of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Pain in individuals with multiple sclerosis, knee prosthesis, and post-herpetic neuralgia: learning from focus group patients' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0320-5

Symptomatic medication use in multiple sclerosis

21 January 2018

1 reference

12 December 2020

Pain and sensory complaints in multiple sclerosis

1 reference

12 December 2020

Pain in chronic multiple sclerosis

1 reference

12 December 2020

Trigeminal neuralgia and multiple sclerosis: demonstration of the plaque in an operative case

1 reference

12 December 2020

Trigeminal neuralgia in multiple sclerosis

1 reference

12 December 2020

MRI of the central nervous system in MS patients with and without pain

1 reference

12 December 2020

Pain in portuguese patients with multiple sclerosis

1 reference

12 December 2020

The pain experience of a multiple sclerosis population: a descriptive study

1 reference

12 December 2020

Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis

1 reference

12 December 2020

Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis

1 reference

12 December 2020

Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection

1 reference

12 December 2020

Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis

1 reference

12 December 2020

Tiagabine for treating painful tonic spasms in multiple sclerosis: a pilot study

1 reference

12 December 2020

Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study

1 reference

12 December 2020

Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue

1 reference

12 December 2020

Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis

1 reference

12 December 2020

Persistent pain and uncomfortable sensations in persons with multiple sclerosis

1 reference

12 December 2020

Comparison of carbamazepine rash in multiple sclerosis and epilepsy

1 reference

12 December 2020

Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations

1 reference

12 December 2020

Topiramate relieves refractory trigeminal neuralgia in MS patients

1 reference

12 December 2020

Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis

1 reference

12 December 2020

Chronic and acute pain syndromes in patients with multiple sclerosis

1 reference

12 December 2020

The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy

1 reference

12 December 2020

Pain in Patients With Multiple Sclerosis

1 reference

12 December 2020

Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients

1 reference

12 December 2020

Pain in multiple sclerosis

1 reference

12 December 2020

Trigeminal neuralgia (tic douloureux): MR imaging assessment

1 reference

12 December 2020

Botulinum toxin treatment of painful tonic spasms in multiple sclerosis

1 reference

12 December 2020

Pain in multiple sclerosis patients. A prospective study using the Mc Gill Pain Questionnaire

1 reference

12 December 2020

Central pain in multiple sclerosis--prevalence and clinical characteristics

1 reference

12 December 2020

Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients

1 reference

12 December 2020

Glossopharyngeal neuralgia and MS

1 reference

12 December 2020

Chronic pain in a large community sample of persons with multiple sclerosis

1 reference

12 December 2020

Symptomatic treatment in multiple sclerosis

1 reference

12 December 2020

Association between comorbidity and clinical characteristics of MS.

1 reference

12 December 2020

The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study

1 reference

12 December 2020

Usefulness of trigeminal somatosensory evoked potentials to detect subclinical trigeminal impairment in multiple sclerosis patients

1 reference

12 December 2020

Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia

1 reference

12 December 2020

Worsening of symptoms of multiple sclerosis associated with carbamazepine

1 reference

12 December 2020

Illness and demographic correlates of chronic pain among a community-based sample of people with multiple sclerosis

1 reference

12 December 2020

Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: A behavioural and pharmacological study

1 reference

12 December 2020

10.1007/S11910-012-0320-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1053537306

0 references

1 reference